139 related articles for article (PubMed ID: 27386018)
1. PTCH-1 and MDM2 expression in ameloblastoma from a West African sub-population: implication for chemotherapeutics.
Udeabor SE; Adisa AO; Lawal AO; Barbeck M; Booms P; Sader RA; Ghanaati S
Pan Afr Med J; 2015; 20():140. PubMed ID: 27386018
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity of the PTCH gene in ameloblastoma.
Farias LC; Gomes CC; Brito JA; Galvão CF; Diniz MG; de Castro WH; Bernardes Vde F; De Marco LA; Gomez RS
Hum Pathol; 2012 Aug; 43(8):1229-33. PubMed ID: 22221699
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of p53 and murine double minute 2 protein in odontogenic keratocyst versus variants of ameloblastoma.
Singh A; Jain A; Shetty DC; Rathore AS; Juneja S
J Cancer Res Ther; 2020; 16(3):521-529. PubMed ID: 32719261
[TBL] [Abstract][Full Text] [Related]
4. p53 gene status and expression of p53, MDM2, and p14 proteins in ameloblastomas.
Kumamoto H; Izutsu T; Ohki K; Takahashi N; Ooya K
J Oral Pathol Med; 2004 May; 33(5):292-9. PubMed ID: 15078490
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of MDM2 protein in ameloblastomas as compared to adenomatoid odontogenic tumor.
Krishna A; Kaveri H; Naveen Kumar RK; Kumaraswamy KL; Shylaja S; Murthy S
J Cancer Res Ther; 2012; 8(2):232-7. PubMed ID: 22842367
[TBL] [Abstract][Full Text] [Related]
6. The immunoprofile of odontogenic keratocyst (keratocystic odontogenic tumor) that includes expression of PTCH, SMO, GLI-1 and bcl-2 is similar to ameloblastoma but different from odontogenic cysts.
Vered M; Peleg O; Taicher S; Buchner A
J Oral Pathol Med; 2009 Aug; 38(7):597-604. PubMed ID: 19473442
[TBL] [Abstract][Full Text] [Related]
7. The role of MDM2 in the proliferative activity of ameloblastoma.
Sandra F; Nakamura N; Kanematsu T; Hirata M; Ohishi M
Oral Oncol; 2002 Feb; 38(2):153-7. PubMed ID: 11854062
[TBL] [Abstract][Full Text] [Related]
8. Association of MDM2 Overexpression in Ameloblastomas with
Tosios KI; Kalogirou EM; Koutlas IG
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396916
[TBL] [Abstract][Full Text] [Related]
9. Anti-apoptotic role of the sonic hedgehog signaling pathway in the proliferation of ameloblastoma.
Kanda S; Mitsuyasu T; Nakao Y; Kawano S; Goto Y; Matsubara R; Nakamura S
Int J Oncol; 2013 Sep; 43(3):695-702. PubMed ID: 23835807
[TBL] [Abstract][Full Text] [Related]
10. DNA damage response activation and cell cycle dysregulation in infiltrative ameloblastomas: A proposed model for ameloblastoma tumor evolution.
Diniz MG; Guimarães BVA; Pereira NB; de Menezes GHF; Gomes CC; Gomez RS
Exp Mol Pathol; 2017 Jun; 102(3):391-395. PubMed ID: 28454892
[No Abstract] [Full Text] [Related]
11. Expression of PTCH gene in ameloblastoma and odontogenic keratocyst: A comparative study.
Srinagesh S; Sahana NS; Suganya G; Renuga S; Natarajan S; Kulkarni M
J Oral Maxillofac Pathol; 2023; 27(2):427. PubMed ID: 37854928
[TBL] [Abstract][Full Text] [Related]
12. BRAFV600E mutation in the diagnosis of unicystic ameloblastoma.
Pereira NB; Pereira KM; Coura BP; Diniz MG; de Castro WH; Gomes CC; Gomez RS
J Oral Pathol Med; 2016 Nov; 45(10):780-785. PubMed ID: 27084044
[TBL] [Abstract][Full Text] [Related]
13. Comment on: F. Sandra et al. "The role of MDM2 in the proliferative activity of ameloblastoma", oral oncology 2002;38(2): 153-57.
O'Neill lD
Oral Oncol; 2002 Dec; 38(8):806. PubMed ID: 12570062
[No Abstract] [Full Text] [Related]
14. Ameloblastoma-Clinical, radiological, and therapeutic findings.
Kreppel M; Zöller J
Oral Dis; 2018 Mar; 24(1-2):63-66. PubMed ID: 29480593
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical comparison of the expression of p53 and MDM2 proteins in ameloblastomas and keratocystic odontogenic tumors.
Sharifi-Sistani N; Zartab H; Babakoohi S; Saghravanian N; Jamshidi S; Esmaili H; Mohtasham N; Zamanzadeh M; Abbaszadeh-Bidokhty H
J Craniofac Surg; 2011 Sep; 22(5):1652-6. PubMed ID: 21959406
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of p53 protein in ameloblastoma types.
el-Sissy NA
East Mediterr Health J; 1999 May; 5(3):478-89. PubMed ID: 10793827
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical biomarkers in ameloblastomas.
do Canto AM; Rozatto JR; Schussel JL; de Freitas RR; Hasséus B; Braz-Silva PH
Acta Odontol Scand; 2016 Nov; 74(8):585-590. PubMed ID: 27571891
[TBL] [Abstract][Full Text] [Related]
18. Heparanase gene and protein expression in ameloblastoma: possible role in local invasion of tumor cells.
Nagatsuka H; Han PP; Tsujigiwa H; Siar CH; Gunduz M; Sugahara T; Sasaki A; Nakajima M; Naomoto Y; Nagai N
Oral Oncol; 2005 May; 41(5):542-8. PubMed ID: 15878761
[TBL] [Abstract][Full Text] [Related]
19. Allelic loss of the ING gene family loci is a frequent event in ameloblastoma.
Borkosky SS; Gunduz M; Beder L; Tsujigiwa H; Tamamura R; Gunduz E; Katase N; Rodriguez AP; Sasaki A; Nagai N; Nagatsuka H
Oncol Res; 2010; 18(10):509-18. PubMed ID: 20681410
[TBL] [Abstract][Full Text] [Related]
20. Relative expression of α-smooth muscle actin and matrix metalloproteinases-2 in ameloblastoma of a black African sub-population.
Adisa AO; Udeabor SE; Adeyemi BF; Alica K; Booms P; Ghanaati S; Sader RA
Ann Afr Med; 2015; 14(4):188-92. PubMed ID: 26470744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
